Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.93 |
| ▸ | CA6 | P23280 | 5/20 | 0.93 |
| ▸ | CA7 | P43166 | 5/20 | 0.93 |
| ▸ | CA9 | Q16790 | 5/20 | 0.93 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.93 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.93 |
| ▸ | CA2 | P00918 | 4/20 | 0.93 |
| ▸ | CA4 | P22748 | 4/20 | 0.93 |
| ▸ | CA5A | P35218 | 4/20 | 0.93 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.93 |
| ▸ | F13A1 | P00488 | 2/20 | 0.93 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.93 |
| ▸ | THPO | P40225 | 2/20 | 0.93 |
| ▸ | CASP2 | P42575 | 2/20 | 0.93 |
| ▸ | MEN1 | O00255 | 2/20 | 0.93 |
| ▸ | RECQL | P46063 | 2/20 | 0.93 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.93 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.93 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.93 |
| ▸ | CA3 | P07451 | 3/20 | 0.87 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3471433 | 1.00 | CA12 (0.93) | CA12CA6CA7CA9CA14 | |
| SCHEMBL4288395 | 1.00 | CA12 (0.93) | CA12CA6CA7CA9CA14 | |
| SCHEMBL3159000 | 1.00 | CA12 (0.93) | CA12CA6CA7CA9CA14 | |
| SCHEMBL3165616 | 0.97 | CA12 (0.93) | CA12CA6CA7CA9CA14 | |
| SCHEMBL31129279 | 0.97 | CA12 (0.87) | CA12CA6CA7CA9CA14 | |
| SCHEMBL3158875 | 0.97 | CA12 (0.93) | CA12CA6CA7CA9CA14 | |
| SCHEMBL3169101 | 0.97 | CA12 (0.93) | CA12CA6CA7CA9CA14 | |
| SCHEMBL333029 | 0.97 | CA12 (0.93) | CA12CA6CA7CA9CA14 | |
| SCHEMBL868754 | 0.96 | CA12 (0.86) | CA12CA6CA7CA9CA14 | |
| Thermine SCHEMBL181589 | 0.96 | CA12 (0.86) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1342413-A1 | Plant protection formulation containing a copper-polyamine chelate | BMS Micro-Nutrients N.V. (BE) | 2003-09-10 | — | — | EP | claimed |
| US-6172261-B1 | BIOSYNTHESIS USING CHAIN EXTENSION | ORIDIGM CORPORATION | 2001-01-09 | — | — | US | claimed |
| EP-1001927-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003823-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 1999-01-28 | — | — | WO | claimed |
| US-20260125344-A1 | POLYURETHANE-ACETOACETATE COMPOUNDS | PPG INDUSTRIES OHIO, INC. (US) | 2026-05-07 | — | — | US | disclosed |
| US-20250001399-A1 | CELL ADSORPTION MATERIAL AND CELL ADSORPTION COLUMN | TORAY INDUSTRIES, INC. (JP) | 2025-01-02 | — | — | US | disclosed |
| EP-4427768-A1 | CELL ADSORPTION MATERIAL AND CELL ADSORPTION COLUMN | Toray Industries, Inc. (JP) | 2024-09-11 | — | — | EP | disclosed |
| EP-4423059-A2 | POLYURETHANE-ACETOACETATE COMPOUNDS | PPG Industries Ohio, Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| CN-118201657-A | Cell adsorption material and cell adsorption column | 东丽株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-118159519-A | Polyurethane acetoacetate compounds | PPG工业俄亥俄公司 | 2024-06-07 | — | — | CN | disclosed |
| WO-2023074729-A1 | CELL ADSORPTION MATERIAL AND CELL ADSORPTION COLUMN | 東レ株式会社 | 2023-05-04 | — | — | WO | disclosed |
| WO-2023076835-A2 | POLYURETHANE-ACETOACETATE COMPOUNDS | PPG INDUSTRIES OHIO, INC. (US) | 2023-05-04 | — | — | WO | disclosed |
| WO-2001072685-A9 | POLYAMINE ANALOGUES AS CYTOTOXIC AGENTS | ORIDIGM CORP (US) | 2002-10-10 | — | — | WO | disclosed |
| WO-2001092218-A2 | POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 2001-12-06 | — | — | WO | disclosed |
| CN-1067550-C | Calcium receptor active molecules | NPS PHARMA INC (US) | 2001-06-27 | — | — | CN | disclosed |
| EP-1085011-A1 | Novel polyamine analogues as therapeutic and diagnostic agents | ORIDIGM CORPORATION (US) | 2001-03-21 | — | — | EP | disclosed |
| US-6172261-B1 | BIOSYNTHESIS USING CHAIN EXTENSION | ORIDIGM CORPORATION | 2001-01-09 | — | — | US | disclosed |
| EP-1001927-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999003823-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 1999-01-28 | — | — | WO | disclosed |
| CN-1071333-A | CALCIUM RECEPTOR ACTIVE MOLECULES | NPS PHARMA INC (US) | 1993-04-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125344-A1 | POLYURETHANE-ACETOACETATE COMPOUNDS | HAT1, PUF60, GAR1 | CA12 801/4885CA6 810/4885CA7 710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.